Key result
Novel MYH2 variant expands the recessive myopathy spectrum with adult-onset progressive weakness and ophthalmoplegia.
Why the study?
MyHC-related congenital myopathies display variable age of onset and clinical manifestations depending on the mutated isoform, with cardiomyopathy, ophthalmoplegia, and proximal weakness as potential features.
Case Report (n=1)
No
The identification of a novel homozygous truncating MYH2 variant in an adult patient expands the clinical and genetic spectrum of recessive MYH2-related myopathies.
Warrants MYH2 testing in unexplained adult myopathy; extends the clinical and genetic spectrum of recessive disease.
Myosin heavy chain (MyHC)-related congenital myopathies display variable age of onset and clinical manifestations depending on the mutated isoform. Cardiomyopathy, ophthalmoplegia and primarily proximal weakness may be part of the clinical picture. A 57-year-old male patient with a history of arterial hypertension and hyperferritinemia (thalassemic trait) began to experience lower limb proximal weakness at the age of 23 years and he got progressively worse over the years when he also reported mild dyspnea, easy fatigability, fasciculations and a sort of discomfort in the posterior muscles of both thighs even at rest. He had no diplopia or dysphagia. Peculiar clinical features were bilateral exophthalmos, slight eyelid ptosis, limited ocular motility in all gaze directions, marked lower limb proximal weakness with posteromedial thigh hypotrophy and hypertrophic calves with increased consistency. Severe signs of both myopathic and neurogenic degeneration were seen at quadriceps skeletal muscle biopsy. Serum CK values were slightly elevated (less than 300 U/L). His parents are second-degree cousins and have normal serum CK levels, a proband’s first cousin had a diagnosis of muscular dystrophy and died at the age of 60 years, wheelchair bound. A 46-year-old sister is healthy. EMG showed signs of reinnervation in all muscles, myopathic signs being evident in the gastrocnemius muscles. Clear signs of fibro-adipose degeneration were observed at muscle MRI, more evidently so in the semitendinosus, rectus femoris, sartorius, gracilis and gastrocnemius muscles. Genetic analysis revealed the new homozygous variant c.3901G > T in exon 29 of MYH2 gene (NM_017534), predicted to introduce the premature stop codon p.(Glu1301*), thus leading to a diagnosis of MYH2-related myopathy. This variant shows a clear genotype-phenotype correlation, as it leads to a near-complete loss of MyHC IIa expression and results in a recessive myopathy characterized by adult-onset progressive muscle weakness with ophthalmoplegia and myopathic changes consistent with biallelic truncating mutations.
No takes yet. Share an insight, caveat, or question.
Zanotti et al. (2026) conducted a case report in MYH2-related myopathy (n=1). A novel homozygous variant c.3901G>T in the MYH2 gene was identified in a 57-year-old male, expanding the clinical spectrum of recessive MYH2-related myopathy with adult-onset progressive muscle weakness and ophthalmoplegia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: